Thrombin Generation Assay (TGA)

BIOLOGICAL2 trials

Sponsors

Medical University of Vienna, Centre Hospitalier Universitaire de Saint Etienne

Conditions

CancerCoagulation Disorder, BloodCovid19Critical IllnessDisseminated Intravascular CoagulationPulmonary EmbolismSars-CoV2Thrombosis

Unknown Phase

Thrombomodulin-modified Thrombin Generation Assay (TGA-TM) in Patients With Critical Infections

CompletedNCT04356144

Medical University of ViennaCoagulation Disorder, Blood, Covid19, Critical Illness +3

Start: 2020-04-15End: 2021-02-01Updated: 2021-03-23

Thrombin Generation Parameters and Bleeding in Patients Treated With Anticoagulants for Cancer Associated Thrombosis

RecruitingNCT06386107

Centre Hospitalier Universitaire de Saint EtienneCancer, Pulmonary Embolism, Thrombosis

Start: 2025-09-02End: 2028-07-01Target: 212Updated: 2026-08-24